Related Experiment Video
Updated: Feb 24, 2026
05:18
Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
Published on: January 16, 2026
89
Left ventricular assist device: exercise capacity evolution and rehabilitation added value
Michel X Lamotte1, Sara Chimenti1, Gael Deboeck1
1a Department of Physiotherapy , Erasme Hospital , Brussels , Belgium.
Acta Cardiologica
|August 30, 2017
Summary
Left ventricular assist device (LVAD) implantation improves exercise capacity. Cardiac rehabilitation significantly enhances this improvement in LVAD patients, leading to better outcomes.
Area of Science:
- Cardiology
- Medical Devices
- Rehabilitation Medicine
Background:
- Left ventricular assist device (LVAD) implantation is a key treatment for advanced heart failure.
- LVADs offer significant survival benefits but data on exercise capacity evolution and rehabilitation impact are limited.
Purpose of the Study:
- To assess exercise capacity changes in HeartWare® LVAD patients over time.
- To investigate the impact of cardiac rehabilitation on exercise capacity in these patients.
Main Methods:
- A cohort of 62 HeartWare® LVAD patients were studied.
- Cardiopulmonary exercise testing was performed at 6 weeks, 6 months, and 12 months post-implantation.
Main Results:
- Exercise capacity significantly improved in the early post-implantation period.
- Patients undergoing rehabilitation showed significantly better exercise capacity evolution compared to non-rehabilitated patients.
- Some rehabilitated patients achieved near-normal exercise capacity.
Conclusions:
- HeartWare® LVAD implantation leads to early improvements in exercise capacity.
- Cardiac rehabilitation is crucial for optimizing exercise capacity and outcomes in LVAD patients.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
510
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
510
01:22Heart Failure VI: Adjunct Therapies
438
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
438
01:17Exercise and Cardiac Output
2.3K
Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
Sustained exercise increases the muscles' oxygen demand, which can be...
2.3K
01:30Cardiomyopathy II: Dilated Cardiomyopathy
648
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
648
01:30Heart Failure V: Medical Management
399
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
399
01:29Heart Failure II: Pathophysiology
1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K